Opus Point Partners Management, LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 87 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Opus Point Partners Management, LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$671,000
-30.1%
50,000
-50.0%
1.32%
+58.6%
Q4 2017$960,000
-12.6%
100,0000.0%0.83%
-15.7%
Q3 2017$1,098,000
+21.3%
100,0000.0%0.98%
+18.8%
Q2 2017$905,000
+104.8%
100,000
+102.0%
0.83%
+142.4%
Q1 2016$442,000
-44.4%
49,500
-17.5%
0.34%
-34.9%
Q4 2015$795,000
+412.9%
60,000
+306.8%
0.52%
+510.5%
Q3 2015$155,000
-66.2%
14,750
-1.7%
0.09%
-77.7%
Q1 2015$459,00015,0000.38%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders